Valeant Pharmaceuticals has decided to restructure its operations into three...

Valeant Pharmaceuticals has decided to restructure its operations into three segments. Bausch & Lomb and most of the group's international operations will belong to the durable growth segment, which will represent about half of Valeant's total turnover. The group is also considering the disposal of some core and non-core activities ...

Keep reading this article by becoming a member

barrier_image_OIC

Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.